TobraDex ST: A Reliable Treatment for Blepharitis and Inflammation With Increased Ocular Bio-Availability - Episode 1
This program is sponsored by Santen.
Jodi Luchs, MD, FACS
Associate Clinical Professor of Ophthalmology
Hofstra Northwell School of Medicine
Chief Science Advisor
InFocus Capital Partners
Florida Vision Institute
West Palm Beach, Florida
Indication and Usage
For steroid responsive inflammatory ocular conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and chronic anterior uveitis, corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies for which a corticosteroid is indicated and where the risk of superficial bacterial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.
Important Safety Information
Most viral disease of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal disease of ocular structures. Hypersensitivity to any components of the medication.
WARNINGS & PRECAUTIONS:
The most frequent adverse reactions (<4%) to topical ocular tobramycin are hypersensitivity and localized ocular toxicity, including eye pain, eyelid pruritus, eyelid edema, and conjunctival hyperemia.
The reactions due to the steroid component are increased intraocular pressure with possible development of glaucoma, and infrequent optic nerve disorder; subcapsular cataract; and impaired healing.
The development of secondary infection has occurred. Fungal infections of the cornea may occur. Secondary bacterial ocular infection following suppression of host responses also occurs.
Non-ocular adverse events (0.5% to 1%) included headache and increased blood pressure.
Please see the Full Prescribing Information.